Showing 2,361 - 2,380 results of 4,279 for search '"Pharmacology"', query time: 0.08s Refine Results
  1. 2361
  2. 2362
  3. 2363
  4. 2364
  5. 2365
  6. 2366
  7. 2367
  8. 2368
  9. 2369
  10. 2370
  11. 2371
  12. 2372
  13. 2373
  14. 2374

    Matrine Ameliorates Colorectal Cancer in Rats via Inhibition of HMGB1 Signaling and Downregulation of IL-6, TNF-α, and HMGB1 by Huizhen Fan, Chunyan Jiang, Baoyuan Zhong, Jianwen Sheng, Ting Chen, Qingqing Chen, Jingtao Li, Hongchuan Zhao

    Published 2018-01-01
    “…Matrine-related proteins and CRC-related genes and therapeutic targets of matrine in CRC were predicted using a network pharmacology approach. Five targets, including interleukin 6 (IL-6), the 26S proteasome, tumor necrosis factor alpha (TNF-α), transforming growth factor beta 1 (TGF-β1) and p53, and corresponding high-mobility group box 1 (HMGB1) signaling and T helper cell differentiation were thought to be associated with matrine’s mechanism. …”
    Get full text
    Article
  15. 2375

    Biochemical Behaviours of Salmeterol/Fluticasone Propionate in Treating Asthma and Chronic Obstructive Pulmonary Diseases (COPD) by Hilla Mills, Ronald Acquah, Nova Tang, Luke Cheung, Susanne Klenk, Ronald Glassen, Magali Pirson, Alain Albert, Duong Trinh Hoang, Thang Nguyen Van

    Published 2022-01-01
    “…Analysing such therapies is daunting since coadministration interferes with pharmacology and pharmacokinetics of drugs. This work focuses on salmeterol/fluticasone propionate combination and aspects which has to do with administration, monitoring, metabolism, toxicity, and adverse effects.…”
    Get full text
    Article
  16. 2376
  17. 2377

    Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation by Dana Prídavková, Matej Samoš, Tomáš Bolek, Ingrid Škorňová, Jana Žolková, Peter Kubisz, Ján Staško, Marián Mokáň

    Published 2019-01-01
    “…Direct oral anticoagulants (DOACs), direct oral thrombin inhibitor dabigatran, and direct oral factor Xa inhibitors, rivaroxaban, apixaban, and edoxaban, have emerged as a preferred choice for long-term prevention of stroke in AF patients offering potent and predictable anticoagulation and a favorable pharmacology with low risk of interactions. This article reviews the current data regarding the use of DOACs in individuals with T2D and AF.…”
    Get full text
    Article
  18. 2378
  19. 2379
  20. 2380